decoding glp 1 [Season 2] Ep 3: GLP-1 Full-length human GLP-1 receptor structure

Onco Targets Ther (2017) 10:562131

Weight loss is associated with a decrease in PsO severity and improved quality of life (QoL).41,42 Weight loss greater than 5% is associated with a higher rate of minimum disease activity in patients who are obese or overweight and in treatment for PsO.43,44 The Mediterranean diet, which facilitates weight loss, reduces psoriatic lesions.45 Weight loss in patients with HS leads to a notable decrease in the number of lesions and, in some cases, disease remission.46 Dysfunctional adiposity has been associated with worse indices of CVR and Dermatology Quality of Life Index (DLQI) in patients with HS.47 The decrease in fatty tissue is associated with a decrease in molecular mechanisms that characterize the systemic inflammatory state.48 Diet and exercise are the first therapeutic step but these interventions are, however, often insufficient to achieve favorable outcomes in skin diseases, good response to treatment for these conditions, and a decrease in CVR

This rapid growth underscores the increasing adoption of GLP-1 receptor agonists for type 2 diabetes management, driven by their efficacy in glycemic control, weight reduction, and cardiovascular risk mitigation

But it can also create a new problem: eating too little of the foods your body still needs

Tirzepatide and additional dual GLP-1/GIP receptor agonists that could eventually be developed in the future seem to be a promising furthest advance for the management of several cardiometabolic settings